Biochemical sensor implanted at initial biopsy could allow doctors to better monitor, adjust cancer treatments

August 5, 2015 by Chris Berdik, Massachusetts Institute of Technology
Illustration of the tiny biochemical sensor that can be implanted in cancerous tissue during an initial biopsy.

In the battle against cancer, which kills nearly 8 million people worldwide each year, doctors have in their arsenal many powerful weapons, including various forms of chemotherapy and radiation. What they lack, however, is good reconnaissance—a reliable way to obtain real-time data about how well a particular therapy is working for any given patient.

Magnetic resonance imaging and other scanning technologies can indicate the size of a tumor, while the most detailed information about how well a treatment is working comes from pathologists' examinations of tissue taken in biopsies. Yet these methods offer only snapshots of , and the invasive nature of biopsies makes them a risky procedure that clinicians try to minimize.

Now, researchers at MIT's Koch Institute for Integrative Cancer Research are closing that information gap by developing a tiny biochemical sensor that can be implanted in cancerous tissue during the initial biopsy. The sensor then wirelessly sends data about telltale biomarkers to an external "reader" device, allowing doctors to better monitor a patient's progress and adjust dosages or switch therapies accordingly. Making cancer treatments more targeted and precise would boost their efficacy while reducing patients' exposure to serious side effects.

"We wanted to make a device that would give us a chemical signal about what's happening in the tumor," says Michael Cima, the David H. Koch (1962) Professor in Engineering in the Department of Materials Science and Engineering and a Koch Institute investigator who oversaw the sensor's development. "Rather than waiting months to see if the tumor is shrinking, you could get an early read to see if you're moving in the right direction."

Two MIT doctoral students in Cima's lab worked with him on the sensor project: Vincent Liu, now a postdoc at MIT, and Christophoros Vassiliou, now a postdoc at the University of California at Berkeley. Their research is featured in a paper in the journal Lab on a Chip that has been published online.

Measurements without MRI

The developed by Cima's team provide real-time, on-demand data concerning two biomarkers linked to a tumor's response to treatment: pH and dissolved oxygen.

Once implanted, the sensor wirelessly sends data about biomarkers to an external “reader” device, allowing doctors to better monitor a patient’s progress and adjust or switch therapies.

As Cima explains, when is under assault from chemotherapy agents, it becomes more acidic. "Many times, you can see the response chemically before you see a tumor actually shrink," Cima says. In fact, some therapies will trigger an immune system reaction, and the inflammation will make the tumor appear to be growing, even while the therapy is effective.

Oxygen levels, meanwhile, can help doctors gauge the proper dose of a therapy such as radiation, since tumors thrive in low-oxygen (hypoxic) conditions. "It turns out that the more hypoxic the tumor is, the more radiation you need," Cima says. "So, these sensors, read over time, could let you see how hypoxia was changing in the tumor, so you could adjust the radiation accordingly."

The sensor housing, made of a biocompatible plastic, is small enough to fit into the tip of a biopsy needle. It contains 10 microliters of chemical contrast agents typically used for (MRI) and an on-board circuit to communicate with the external reader device.

Devising a power source for these sensors was critical, Cima explains. Four years ago, his team built a similar implantable sensor that could be read by an MRI scanner. "MRI scans are expensive and not easy to make part of routine care," he says. "We wanted to take the next step and put some electronics on the device so we could take these measurements without an MRI."

For power, these new sensors rely on the reader. Specifically, there's a metal coil inside the reader and a much smaller coil in the sensor itself. An electric current magnetizes the coil inside the reader, and that magnetic field creates a voltage in the sensor's coil when the two coils are close together—a process called mutual inductance. The reader sends out a series of pulses, and the sensor "rings back," as Cima puts it. The variation in this return signal over time is interpreted by a computer to which the reader is wired, revealing changes in the targeted biomarkers.

"With these devices, it's like taking blood pressure. It's a simple measurement. You get the readout and move on," says Ralph Weissleder, a radiologist and director of the Center for Systems Biology lab at Massachusetts General Hospital who is familiar with the research. "Whatever you can do right then and there without any complicated testing, the better it is.

Additional applications

Cima's team successfully tested the sensors in lab experiments, including implanting them in rodents. While the sensors were only implanted for a few weeks, Cima believes they could be used to monitor a person's health over many years.

"There are thousands of people alive today, because they have implantable electronics, like pacemakers and defibrillators," he says. "We're making these sensors out of materials that are in these kinds of long-term implants, and given that they're so small, I don't think there will be a problem."

These initial experiments showed that the sensors could quickly, reliably, and accurately detect pH and oxygen concentration in tissue. The researchers next want to see how well the sensors do measuring changes in pH over an extended period of time.

"I want to push these probes so we can use them to monitor response," Cima says. "We did a little bit of that in these experiments, but we need to make that really robust."

While the primary application of these sensors would be cancer care, Cima is also eager to collaborate with researchers in other fields, such as environmental science. "For example, you could use these to measure dissolved oxygen or pH from a lot of different sites all over a pond or a lake," Cima says. "I'm excited about using these sensors to bring big data to environmental monitoring."

Explore further: MRI sensor that enables long-term monitoring of oxygen levels could aid cancer diagnosis, treatment

More information: "Miniaturized, biopsy-implantable chemical sensor with wireless, magnetic resonance readout." Lab Chip, 2015, Advance Article DOI: 10.1039/C5LC00546A

Related Stories

Implantable Device Offers Continuous Cancer Monitoring

July 21, 2009

( -- Surgical removal of a tissue sample is now the standard for diagnosing cancer. Such procedures, known as biopsies, are accurate but offer only a snapshot of the tumor at a single moment in time.

Implant monitors tumors

May 13, 2009

Surgical removal of a tissue sample is now the standard for diagnosing cancer. Such procedures, known as biopsies, are accurate but only offer a snapshot of the tumor at a single moment in time.

Detecting whether a heart attack has occurred

February 14, 2011

During about 30 percent of all heart attacks, the patient experiences no symptoms. However, unmistakable signs of the attack remain in the bloodstream for days. MIT researchers, working with Massachusetts General Hospital’s ...

Recommended for you

Fish-inspired material changes color using nanocolumns

March 20, 2019

Inspired by the flashing colors of the neon tetra fish, researchers have developed a technique for changing the color of a material by manipulating the orientation of nanostructured columns in the material.

Researchers shed new light on the origins of modern humans

March 20, 2019

Researchers from the University of Huddersfield, with colleagues from the University of Cambridge and the University of Minho in Braga, have been using a genetic approach to tackle one of the most intractable questions of ...

One transistor for all purposes

March 20, 2019

In mobiles, fridges, planes – transistors are everywhere. But they often operate only within a restricted current range. LMU physicists have now developed an organic transistor that functions perfectly under both low and ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.